登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Medicalxpress，12月20日，Oxford-AstraZeneca COVID-19 vaccine protection wanes after three months, study suggests》

  • 来源专题：COVID-19科研动态监测
  • 编译者： YUTING
  • 发布时间：2021-12-24

  • he protection offered by the Oxford-AstraZeneca COVID-19 vaccine declines after three months of receiving two doses, a study says.

    The findings—drawn from datasets in two countries—suggest that booster programs are needed to help maintain protection from severe disease in those vaccinated with Oxford-Astra Zeneca, experts say.

    Researchers from Scotland and Brazil analyzed data for two million people in Scotland and 42 million people in Brazil who had been vaccinated with the Oxford-Astra Zeneca vaccine.

    In Scotland, when compared with two weeks after receiving a second dose, there was approximately a fivefold increase in the chance of being hospitalized or dying from COVID-19 nearly five months after being double vaccinated.

    The decline in effectiveness begins to first appear at around three months, when the risk of hospitalization and death is double that of two weeks after the second dose, experts say.

    The risk increases threefold just short of four months after the second vaccine dose. Similar numbers were seen for Brazil.

    Researchers were able to compare data between Scotland and Brazil as they had a similar interval between doses—12 weeks—and initial prioritization of who was vaccinated—people at highest risk of severe disease and healthcare workers.

  • 原文来源：https://medicalxpress.com/news/2021-12-oxford-astrazeneca-covid-vaccine-wanes.html
75浏览量
原文链接
相关报告

  • 《Medicalxpress，2月16日，Study suggests increased risk of mental health disorders after COVID-19 infection》
    • 来源专题：COVID-19科研动态监测
    • 编译者：YUTING
    • 发布时间：2022-03-02
    • A study published by The BMJ today finds that COVID-19 is associated with an increased risk of mental health disorders, including anxiety, depression, substance use, and sleep disorders, up to one year after initial infection. The findings suggest that tackling mental health disorders among survivors of COVID-19 should be a priority. Some studies have suggested that people with COVID-19 might be at increased risk of anxiety and depression, but they included only a small selection of mental health outcomes and tracked patients over a maximum of six months. A comprehensive assessment of the mental health manifestations in people with COVID-19 at one year has not yet been undertaken. To address this, researchers used data from the US Department of Veterans Affairs national healthcare databases to estimate the risks of mental health outcomes in people who survived at least 30 days after a positive polymerase chain reaction (PCR) test result between March 2020 and January 2021. They identified data for 153,848 individuals and matched them to two control groups without COVID-19: 5,637,840 contemporary controls and 5,859,251 historical controls who predated the pandemic. Participants were mostly white men with an average age of 63 years. The COVID-19 group was further divided into those who were or were not admitted to hospital during the acute phase of infection, and information was collected on potentially influential factors including age, race, sex, lifestyle, and medical history. The researchers then followed all three groups for one year to estimate the risks of a set of prespecified mental health outcomes, including anxiety, depression and stress disorders, substance use disorders, neurocognitive decline, and sleep disorders. Compared with the non-infected control group, people with COVID-19 showed a 60% higher risk of any mental health diagnosis or prescription at one year (equivalent to an additional 64 per 1,000 people). When the researchers examined mental health disorders separately, they found that COVID-19 was associated with an additional 24 per 1,000 people with sleep disorders at one year, 15 per 1,000 with depressive disorders, 11 per 1,000 with neurocognitive decline, and 4 per 1,000 with any (non-opioid) substance use disorders.
    104浏览量
    原文链接

  • 《CIDRAP，2月15日，Study suggests maternal COVID-19 vaccination protects babies》
    • 来源专题：COVID-19科研动态监测
    • 编译者：YUTING
    • 发布时间：2022-02-23
    • COVID-19 vaccination during pregnancy—already known to protect women from hospitalization and severe complications—can also protect babies younger than 6 months, researchers reported today. In other COVID-19 research developments, a separate team that looked at COVID-19 hospitalizations in kids found that levels jumped dramatically during the Omicron variant surge, especially in kids younger than 4, a group not eligible yet for vaccination. Real-world evidence of baby benefits The study on the impact of COVID-19 vaccination during pregnancy on the youngest infants examined hospitalization trends across 20 children's hospitals in 17 states from July 2021 through January 2022. The team published its findings today in an early online edition of Morbidity and Mortality Weekly Report (MMWR). At a Centers for Disease Control and Prevention (CDC) briefing today, Dana Meaney-Delman, MD, MPH, who wasn't involved in the study and heads the CDC's Infant Outcomes Monitoring Research and Prevention Branch, said scientists already now that SARS-CoV-2 antibodies are found in umbilical cord blood and can cross the placenta. However, she said it wasn't known if the maternal antibodies provided any protection to babies. "Now we have real-world evidence in babies younger than 6 months," she said. The study authors found that babies born to pregnant women who had received two doses of an mRNA vaccine were 61% less likely than those born to unvaccinated moms to be hospitalized with a COVID-19 infection. Of 176 babies hospitalized with COVID-19 over the study period, 84% were born to mothers who were unvaccinated during pregnancy. Of 43 infants who were admitted to the intensive care unit, 88% had mothers who were unvaccinated. Of the critically ill babies, one died—a child of an unvaccinated mother. Effectiveness was lower if a woman was vaccinated in early pregnancy, during the first 20 weeks, with protection at 32% versus 80% in later pregnancy. But researchers warn that the confidence interval is wide and that the pattern should be interpreted with caution. Senior author Manish Patel, MD, with the CDC's COVID-19 Emergency Response Team, said the numbers were too small to look at the impact of vaccination by trimester. And Delman said there aren't any changes in recommendations that relate to the timing of COVID-19 vaccination during pregnancy. She said vaccination levels in pregnant women are increasing and are encouraging, but aren't where health experts need them to be. Maternal vaccination has been found to help young infants against other infections such as flu and pertussis, and now extend to COVID-19. "This new study will undoubtedly be factoring into my counseling sessions," Meaney-Delman said. Omicron hits youngest kids hardest In a snapshot of COVID-19 hospitalizations in children and adolescents, another research team examined data from 14 states covering July 2021 to January 2022, a time that covered Delta circulation, then quickly transitioned to Omicron in December. Their findings also appear in an early online edition of MMWR. Once the Omicron variant became dominant, hospitalizations in children and adolescents reached levels that were four time higher than those of Delta's peak. The largest increase in hospitalizations was in children ages 0 to 4, who weren't eligible for vaccination. During the study period, adolescents ages 12 to 17 were the only pediatric group approved for COVID-19 vaccination during the entire study period. When researchers compared their hospitalizations to that of unvaccinated peers, they found that levels were six times higher in the unvaccinated group. "All persons who are eligible for vaccination should receive and stay up to date with COVID-19 vaccines to reduce the risk for severe disease for themselves and others with whom they come into contact, including children who are currently too young to be vaccinated," the group wrote.
    97浏览量
    原文链接